GastroenterologyNews.net

Gastroenterology Xagena

Search results for "Cimzia"

A single 400 mg injection of Cimzia ( Certolizumab pegol, CDP 870 ) every four weeks was effective in maintaining control of the signs and symptoms of Crohn's disease following induction therapy, acco ...


A Phase III trial ( PRECiSE 1 ) data have demonstrated that when compared with placebo, a significantly greater proportion of moderate to severe Crohn's disease patients achieved clinical response wit ...


Safe, effective treatment options exist for patients with mild-to-moderate Crohn’s disease or ulcerative colitis. However, a significant proportion of patients with moderate-to-severe Crohn’s disease ...


A systematic review and meta-analysis of data from randomized controlled trials ( RCTs ) to evaluate the efficacy and safety of Certolizumab pegol ( Cimzia ) was performed. A total of five RCTs, in ...